Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preemptive Co-infiltration of Triamcinolone Acetonide With Ropivacaine for Postoperative Pain in Patients Undergoing Major Spinal Surgery

NCT06801587 is registered in ClinicalTrials.gov with Fang Luo as lead sponsor.

NCT NCT06801587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06801587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preemptive Co-infiltration of Triamcinolone Acetonide With Ropivacaine for Postoperative Pain in Patients Undergoing Major Spinal Surgery
Lead sponsor
Fang Luo
Phase
Phase 4
Overall status
Completed
Start date
February 5, 2025
Completion date
August 10, 2025
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative